Valuation Albert David Limited NSE India S.E.

Stocks

Delayed NSE India S.E. 11:01:56 06/10/2026 BST			5-day change	1st Jan Change
839.10 ^INR	+0.32%		-4.25%	+13.92%

08-06	Albert David Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-06	Albert David Limited Approves Appointment of Mr. Amit Mahla as Whole-Time Director, effective 19 June, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	2,150	3,034	2,921	6,139	4,630	3,350
Change	-	41.11%	-3.71%	110.15%	-24.58%	-27.65%
Enterprise Value (EV) ¹	677.4	1,343	942.3	3,320	2,317	1,070
Change	-	98.22%	-29.82%	252.36%	-30.23%	-53.81%
P/E	9.71x	8.61x	8.08x	8.14x	26.9x	-224x
PBR	0.88x	1.09x	0.94x	1.6x	1.18x	0.86x
PEG	-	0.1x	3.11x	0x	-0.3x	2x
Capitalization / Revenue	0.87x	0.97x	0.86x	1.69x	1.34x	1x
EV / Revenue	0.27x	0.43x	0.28x	0.92x	0.67x	0.32x
EV / EBITDA	3.82x	3.43x	2.18x	7.21x	102x	22.4x
EV / EBIT	6.21x	4.2x	2.6x	8.29x	-60.5x	-26.6x
EV / FCF	1.98x	3.58x	-21.4x	8.85x	-6.17x	-2.9x
FCF Yield	50.4%	28%	-4.68%	11.3%	-16.2%	-34.5%
Dividend per Share ²	6	9	9	11.5	5	5
Rate of return	1.59%	1.69%	1.76%	1.07%	0.62%	0.85%
EPS ²	38.8	61.78	63.39	132.1	30.14	-2.619
Distribution rate	15.5%	14.6%	14.2%	8.7%	16.6%	-191%
Net sales ¹	2,474	3,135	3,416	3,625	3,458	3,336
EBITDA ¹	177.4	391.5	431.6	460.7	22.66	47.87
EBIT ¹	109.2	319.9	362.4	400.6	-38.27	-40.25
Net income ¹	221.4	352.6	361.7	754.2	172	-14.95
Net Debt ¹	-1,473	-1,691	-1,979	-2,819	-2,313	-2,280
Reference price ²	376.75	531.65	511.90	1,075.75	811.30	587.00
Nbr of stocks (in thousands)	5,707	5,707	5,707	5,707	5,707	5,707
Announcement Date	20/08/21	14/07/22	19/05/23	12/07/24	05/07/25	13/07/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	32.46x	11.79x	23.8x	0.61%	1,019B
JOHNSON & JOHNSON	28.13x	6.24x	17.86x	2.11%	610B
ABBVIE INC.	33.64x	7.86x	16.24x	2.61%	470B
MERCK & CO., INC.	101.52x	5.7x	24.22x	2.45%	344B
ROCHE HOLDING AG	18.95x	4.61x	11.45x	2.87%	336B
NOVARTIS AG	19.74x	5.16x	12.75x	3.1%	266B
ASTRAZENECA PLC	19.84x	4.13x	11.77x	2.15%	241B
AMGEN INC.	25.45x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.74x	6.39x	24.95x	2.28%	179B
Average	26.22x	6.50x	17.21x	2.3%	409.2B
Weighted average by Cap.	31.25x	7.60x	18.53x	1.96%